News

Filter

Current filters:

Gastro-intestinalsOvaSave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

04-01-2015

French biotech firm TxCell on Friday announced a further enhancement to the development of its lead product…

BiotechnologyFerring PharmaceuticalsGastro-intestinalsLicensingOvaSaveResearchTrizell HoldingTxCell

Ferring in up to 76 million euro deal with TxCell for IBD drug Ovasave

Ferring in up to 76 million euro deal with TxCell for IBD drug Ovasave

17-03-2014

French biotech firm TxCell SA and privately-held Switzerland-headquartered Ferring International have…

BiotechnologyFerring PharmaceuticalsFinancialGastro-intestinalsLicensingOvaSaveTxCell

TxCell raises 12.4 million euros to progress OvaSave

26-11-2012

French biotech firm TxCell SA has raised 12.4 million euros ($16.1 million) in a third financing round.…

BiotechnologyFinancialGastro-intestinalsOvaSaveResearchTxCell

COMPANY SPOTLIGHT

Menarini

Back to top